Nervgen Pharma NGEN SEC Filings

NASDAQ NGEN
$2.12 -0.02 (-0.70%)
As of: Sep 10, 2026 · 12:38 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Nervgen Pharma Corp. (NGEN) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index